Clinical Status Assessment

¶¶

Reporting Data Item

Business Justification

Definition

Note: Where ‘NHS Wales Data Dictionary’ the definition is as per the Data Dictionary.

Permissible Values

11. CLINICAL STATUS ASSESSMENT

11.0

ENCDv4.5b (15.1)

 

SPCDv1.0

(9.1)

Death date

To determine survival rates and mortality rates.

Date of patient’s death.

NHS Wales Data Dictionary

 

11.1

NLCA

Toxicity of complications at clinical status assessment

To determine patterns of adverse events associated with a treatment. Required for submission to the national lung cancer audit.

Diagnosis of complications at clinical status assessment. Any morbidity, relevant to previous chemotherapy or radiotherapy treatments that the patient has received, recorded at any subsequent patient contact.

Permissible values are agreed by the clinical steering groups and conform to the requirements of the reporting output specifications. Currently there is no explicit requirement to map to terminologies or classifications. This will be kept under review.

 

For Chemotherapy (only long term adverse effects need to be reported)

     Moderate toxicity

     Severe toxicity

     Death due to toxicity

 

For Radiotherapy (only significant morbidity needs to be reported):

     Moderate toxicity

     Severe toxicity

     Death due to toxicity